BRZ NewsBRZ News
    Markets

    JBS US Shares Target 50% Upside at Itaú BBA Despite Q3 Profit Drop

    Itaú BBA reiterated its buy rating on NYSE-listed JBS N.V. with an $18 price target, pointing to a projected earnings turnaround starting in late 2026.

    Published

    JBS US Shares Target 50% Upside at Itaú BBA Despite Q3 Profit Drop
    AI-generated illustration

    Key takeaways

    • Itaú BBA reiterated its buy rating on JBS N.V. with an $18 price target, per Money Times on November 19, 2026
    • JBS's third-quarter adjusted EBITDA dropped 35.6% to $1.18 billion, per JBS's SEC filing on November 9, 2026
    • JBS's net income plummeted 71.7% to $164.4 million as leverage rose to 3.54 times, per its SEC filing on November 9, 2026
    • BTG Pactual maintained its buy rating on JBS despite trimming its 2027 EBITDA forecast, per Money Times on November 11, 2026

    New York-listed shares of global meatpacking giant JBS N.V. (NYSE: JBS) hold an approximate 50% upside potential despite a third-quarter contraction in profits, according to an analysis published by Money Times on November 19, 2026. On that date, analysts at Itaú BBA—the investment banking arm of Brazil's private lender Itaú Unibanco—reiterated their buy-equivalent recommendation on the agricultural powerhouse, maintaining an $18 price target for year-end 2027. The analysts assert that while margin compression in the North American beef market currently weighs on the stock, a gradual recovery cycle makes the company an attractive turnaround play for foreigners looking to invest in Brazil.

    The bullish stance follows a weaker-than-expected third-quarter earnings report filed with the Securities and Exchange Commission on November 9, 2026. In its quarterly filing, JBS N.V. revealed that consolidated adjusted EBITDA dropped 35.6% year-over-year to $1.18 billion under International Financial Reporting Standards (IFRS). Meanwhile, net income attributable to shareholders plummeted 71.7% to $164.4 million, down from $580.9 million a year earlier, per the same SEC filing. The compression in beef margins, combined with higher working capital needs, pushed JBS's net leverage ratio to 3.54 times adjusted EBITDA for the third quarter of 2026, up from 2.39 times a year prior.

    Despite these short-term operational headwinds, analysts note that investor focus on the Brazil stock market today has already started shifting toward a projected earnings recovery beginning in the fourth quarter of 2026. In its official third-quarter earnings release filed with the Securities and Exchange Commission on November 9, 2026, JBS highlighted that its U.S. beef division returned to positive adjusted EBITDA under U.S. GAAP as monthly margins improved sequentially from July to September. The company noted that industry-wide processing capacity adjustments and the reopening of key U.S.-Mexico cattle crossings, which allowed heavier cattle to reach processors more quickly, supported the recovery in profitability. As reported by Money Times on November 19, 2026, Itaú BBA adjusted its model to reflect a 2% increase in JBS's projected 2027 EBITDA to $5.7 billion, driven by expectations that the U.S. beef division's EBITDA margin will recover to 1% in 2027 compared to an earlier, more conservative forecast of 0.2%.

    Meanwhile, fellow Brazilian investment bank BTG Pactual also maintained its buy recommendation on JBS, though its analysts adopted a slightly more cautious stance on the speed of the American cattle cycle. In an analysis reported by Money Times on November 11, 2026, BTG Pactual trimmed JBS’s 2027 EBITDA forecast to $5.75 billion, warning that tight cattle supply will continue to pressure North American processing plants. The bank's analysts noted that JBS's acquisitions of personal care brand Flora for $542 million and agricultural media group Canal Rural for $11 million are strategic moves that diversify the business but temporarily keep leverage elevated.

    Going forward, the critical metric for global investors to watch will be JBS's fourth-quarter 2026 operating performance, particularly whether the sequential margin improvements in U.S. beef carry over into the new year. If the cattle cycle bottomed out in late 2026 as analysts suggest, JBS is positioned to begin deleveraging toward its historical comfort zone of under 3.0 times, clearing the path for the stock to close its steep valuation discount against global consumer defensive peers.

    In your brokerage app

    American retail investors tracking the jbs brazil share price can gain direct exposure to the global protein supply chain through JBS N.V., which trades on the New York Stock Exchange. The stock is also a significant holding in several exchange-traded funds focused on international consumer defensives and emerging market agribusiness. Among B3 stocks, the company's Brazilian Depositary Receipts (BDRs) trade under the ticker JBSS32, while its parent stock is listed on the B3 exchange as JBSS3.